Edgewise Therapeutics Inc (EWTX)
Edgewise Therapeutics - Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)
Edgewise Therapeutics - Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial
Best Buy Canada Selects Perion as a Full-Stack Partner to Power its Retail DOOH Media Network
FORM 6-K- Company Presentation
BXP Executes 150,000 Square Foot Lease with McDermott Will & Schulte at 343 Madison Avenue
Humana, CenterWell y la National Hispanic Medical Association anuncian a los beneficiarios del Programa de Becas para Médicos Residentes de 2026
HASI Prices $1 Billion of 5.950% Green Senior Unsecured Notes Due 2033
Best Buy Canada Selects Perion as a Full-Stack Partner to Power its Retail DOOH Media Network